Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesOral potassium iodide for the treatment of sporotrichosis
Cochrane Reviews, 10/26/09
Xue S et al. – Potassium iodide is an anti–fungal drug listed in the World Health Organization (WHO) essential drug list and generally thought to be the first choice for cutaneous sporotrichosis including fixed and lymphocutaneous types, in developing countries. No randomised controlled trials (RCTs) of oral potassium iodide versus placebo were found and thus its efficacy and safety could not be analysed in this review. There is a need for randomised placebo controlled trials of oral potassium iodide in this area.
Related Articles
Multiple Subcutaneous Mycetomas caused by Pseudallescheria boydii: Response to therapy with oral potassium iodide solution
Journal of Infection, 10/12/09
Relevance Score: 66%
Zoonotic sporotrichosis of lymphocutaneous type in a man acquired from a domesticated feline source: report of a first case in southern Karnataka, India
International Journal of Dermatology, 10/30/09
Relevance Score: 43%
Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09
Relevance Score: 43%
Effect of Potassium Citrate Therapy on the Risk of Renal Stone Formation During Spaceflight
The Journal of Urology, 10/22/09
Relevance Score: 43%
Iodide protects hyaluronate from oxidative stress
Spektrum der Augenheilkunde, 10/01/09
Relevance Score: 43%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09
How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/19/09
Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/19/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Juvenile bullous pemphigoid: the presentation and follow-up of six cases
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Is there any relation between serum insulin and insulin-like growth factor-I in non-diabetic patients with skin tag
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas
Journal of the European Academy of Dermatology and Venereology, 12/18/09
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09
Long-Term Complete Regression of Nodal Marginal Zone Lymphoma Transformed Into Diffuse Large B-Cell Lymphoma With Highly Active Antiretroviral Therapy Alone in Human Immunodeficiency Virus Infection
The American Journal of the Medical Sciences, 12/19/09
Management of HIV-Infected Patients With ESRD
Advances In Chronic Kidney Disease , 12/18/09
Sponsor
Article Search
Sponsor
Sponsor